VISTIN PHARMA ASA (VISTN.OL) Stock Income Statement
OSL:VISTN - Euronext Oslo - NO0010734122 - Common Stock - Currency: NOK
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 429.50M | 435.39M | 287.68M | 275.81M | 253.16M | |||
| Cost Of Goods | 149.97M | 176.64M | 138.06M | 96.10M | 73.29M | |||
| Gross Profit | 279.53M | 258.75M | 149.61M | 179.72M | 179.87M | |||
| Operating Expenses | 194.24M | 190.15M | 155.71M | 146.47M | 134.32M | |||
| Selling, General, and Administrative Expenses | 94.22M | 93.14M | 78.97M | 73.43M | 72.50M | |||
| Operating Income | 85.30M | 68.60M | -6.09M | 33.25M | 45.55M | |||
| Interest Income/Expense | -4.84M | -9.97M | 400.00K | -1.22M | 13.25M | |||
| Other Income/Expense | N/A | -112.00K | -313.00K | -35.00K | -183.07M | |||
| Income Before Taxes | 80.45M | 58.52M | -6.01M | 32.00M | -124.27M | |||
| Income Tax | 17.77M | 12.92M | -1.29M | 7.13M | -27.32M | |||
| Net Income | 62.75M | 45.60M | -4.72M | 24.87M | -96.95M | |||
| EBITDA | N/A | 85.94M | 6.18M | 43.86M | 55.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.41 | 1.03 | -0.11 | 0.56 | -2.19 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 65.08% | 59.43% | 52.01% | 65.16% | 71.05% | |||
| Profit Margin | 14.61% | 10.47% | -1.64% | 9.02% | -38.30% | |||
| Operating Profit Margin | 19.86% | 15.76% | -2.12% | 12.06% | 17.99% | |||
All data in NOK